PMID- 15759260 OWN - NLM STAT- MEDLINE DCOM- 20050627 LR - 20201113 IS - 1552-4825 (Print) IS - 1552-4825 (Linking) VI - 134 IP - 4 DP - 2005 May 1 TI - Retrospective family study of childhood medulloblastoma. PG - 399-403 AB - Medulloblastoma is the most common malignant central nervous system tumor of childhood and can occur sporadically or in association with inherited cancer susceptibility syndromes such as the nevoid basal cell carcinoma syndrome (NBCCS). To determine whether an association existed between the risk of developing medulloblastoma and undiagnosed syndromes, we retrospectively reviewed clinical data on 33 patients with medulloblastoma from a single institution and compared them with their unaffected relatives (n = 46). Six patients had tumors showing desmoplastic histology. Two of the six met diagnostic criteria for NBCCS. One NBCCS patient had a missense mutation of patched-1 (PTCH1); the other had no identifiable PTCH1 mutation. Two patients with isolated desmoplastic medulloblastoma had an insertion and splice site mutation, respectively, in suppressor of fused (SUFU). All patients with nondesmoplastic medulloblastoma histology received molecular testing for SUFU. None of these patients had an identifiable mutation in PTCH1 or SUFU. We performed a clinical evaluation for Greig cephalopolysyndactyly syndrome (GCPS) in four medulloblastoma families, who exhibited macrocephaly as the only finding consistent with the diagnosis of GCPS. Molecular analysis of GLI3 in these four families was negative. There was a paucity of clinical findings among the majority of medulloblastoma patients in this study group to suggest a definable cancer genetic syndrome. We conclude that clinically recognizable syndromes are uncommon among patients with medulloblastoma, however, PTCH1 and SUFU mutations are present at a low but significant frequency. CI - 2005 Wiley-Liss, Inc. FAU - Ng, David AU - Ng D AD - Genetic Epidemiology Branch, DCEG, NCI, NIH, DHHS, Bethesda, Maryland, USA. davidng@mail.nih.gov FAU - Stavrou, Theodora AU - Stavrou T FAU - Liu, Ling AU - Liu L FAU - Taylor, Michael D AU - Taylor MD FAU - Gold, Bert AU - Gold B FAU - Dean, Michael AU - Dean M FAU - Kelley, Michael J AU - Kelley MJ FAU - Dubovsky, Elizabeth C AU - Dubovsky EC FAU - Vezina, Gilbert AU - Vezina G FAU - Nicholson, H S AU - Nicholson HS FAU - Byrne, Julianne AU - Byrne J FAU - Rutka, James T AU - Rutka JT FAU - Hogg, David AU - Hogg D FAU - Reaman, Gregory H AU - Reaman GH FAU - Goldstein, Alisa M AU - Goldstein AM LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Am J Med Genet A JT - American journal of medical genetics. Part A JID - 101235741 RN - 0 (DNA-Binding Proteins) RN - 0 (GLI3 protein, human) RN - 0 (Kruppel-Like Transcription Factors) RN - 0 (Nerve Tissue Proteins) RN - 0 (PTCH1 protein, human) RN - 0 (Patched Receptors) RN - 0 (Patched-1 Receptor) RN - 0 (Receptors, Cell Surface) RN - 0 (Repressor Proteins) RN - 0 (SUFU protein, human) RN - 0 (Transcription Factors) RN - 0 (Zinc Finger Protein Gli3) RN - 9007-49-2 (DNA) SB - IM EIN - Am J Med Genet A. 2005 Jul 15;136(2):226 MH - Adolescent MH - Adult MH - Cerebellar Neoplasms/genetics/*pathology MH - Child MH - Child, Preschool MH - DNA/chemistry/genetics MH - DNA Mutational Analysis MH - DNA-Binding Proteins/genetics MH - Female MH - Humans MH - Infant MH - Kruppel-Like Transcription Factors MH - Male MH - Medulloblastoma/genetics/*pathology MH - Mutation MH - Nerve Tissue Proteins/genetics MH - Patched Receptors MH - Patched-1 Receptor MH - Pedigree MH - Receptors, Cell Surface/genetics MH - Repressor Proteins/genetics MH - Retrospective Studies MH - Transcription Factors/genetics MH - Zinc Finger Protein Gli3 EDAT- 2005/03/11 09:00 MHDA- 2005/06/28 09:00 CRDT- 2005/03/11 09:00 PHST- 2005/03/11 09:00 [pubmed] PHST- 2005/06/28 09:00 [medline] PHST- 2005/03/11 09:00 [entrez] AID - 10.1002/ajmg.a.30653 [doi] PST - ppublish SO - Am J Med Genet A. 2005 May 1;134(4):399-403. doi: 10.1002/ajmg.a.30653.